17α-Alkan (or alkyn) amide derivatives of estradiol as inhibitors of steroid-sulfatase activity

被引:18
作者
Boivin, RP [1 ]
Labrie, F [1 ]
Poirier, D [1 ]
机构
[1] Univ Laval, Ctr Hosp Univ Quebec, Med Res Ctr, Med Chem Div,Lab Mol Endocrinol, Quebec City, PQ G1V 4G2, Canada
基金
英国医学研究理事会;
关键词
steroid sulfatase; inhibitor; enzyme; steroid; estradiol; alkylamide; cancel;
D O I
10.1016/S0039-128X(99)00060-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To develop inhibitors of steroid sulfatase without residual estrogenic activity, we have designed a series of estradiol (E-2) derivatives bearing an alkan (or alkyn) amide side chain at position 17 alpha. A hydrophobic alkyl group was selected from our previous study where 17 alpha-octyl-E-2 was found to inhibit strongly the steroid-sulfatase activity. Furthermore, it is known that an alkylamide side chain blocks the estrogen-receptor activation. Starting from ethynylestradiol, the chemical synthesis of target compounds was short and efficient with overall yields of 22-42% (3 or 4 steps). Among these compounds, N-octyl,N-methyl-3-(3',17' beta-dihydroxy-1',3',5'(10')-estratrien-17' alpha-yl)-propanamide (15) was the most potent inhibitor, with an IC50 value of 0.08 mu M for the transformation of estrone sulfate (E1S) to estrone (E-1) by homogenated JEG-3 cells. N-butyl, N-hexyl, and N,N-dioctyl propanamide derivatives of E-2 (IC50 values of 6.4, 2.8, and >20 mu M, respectively) were less potent inhibitors than N-octyl analog 15. Furthermore, the unsaturated propynamide analog of 15 gave lower inhibition (four times) than the saturated compound. Compound 15 is also about 100-fold more effective in interacting with the enzyme than substrate E1S itself. The ability of target compounds to bind the estrogen receptor, to stimulate the proliferation of estrogen-sensitive ZR-75-1 cells, or to inhibit the E-2-stimulation of ZR-75-1 cells was also evaluated. Although a mixed estrogenic/anti-estrogenic activity was obtained for tested compounds at 1 mu M, no estrogenic activity was observed at 0.03 mu M for 15. In conclusion, a promising inhibitor of steroid-sulfatase activity was obtained by introducing a hydrophobic octyl group in a 17 alpha-propanamide side chain of E-2, but further structure-activity relationships (SAR) studies are necessary to minimize the residual estrogenic activity. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:825 / 833
页数:9
相关论文
共 40 条
[1]  
BOWLER J, 1989, Steroids, V54, P71, DOI 10.1016/0039-128X(89)90076-7
[2]   Aromatase inhibitors in advanced breast cancer: Mechanism of action and clinical implications [J].
Brodie, AMH ;
Njar, VCO .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 66 (1-2) :1-10
[3]   AROMATASE INHIBITORS - MECHANISMS OF STEROIDAL INHIBITORS [J].
BRUEGGEMEIER, RW .
BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (01) :31-42
[4]  
BUCOURT R, 1978, J BIOL CHEM, V253, P8221
[5]   SYNTHETIC ANTIESTROGENS MODULATE INDUCTION OF PS2 AND CATHEPSIN-D MESSENGER-RIBONUCLEIC-ACID BY GROWTH-FACTORS AND ADENOSINE-3',5'-MONOPHOSPHATE IN MCF7 CELLS [J].
CHALBOS, D ;
PHILIPS, A ;
GALTIER, F ;
ROCHEFORT, H .
ENDOCRINOLOGY, 1993, 133 (02) :571-576
[6]   11-BETA-AMIDOALKYL ESTRADIOLS, A NEW SERIES OF PURE ANTIESTROGENS [J].
CLAUSSNER, A ;
NEDELEC, L ;
NIQUE, F ;
PHILIBERT, D ;
TEUTSCH, G ;
VANDEVELDE, P .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 41 (3-8) :609-614
[7]   D-ring allyl derivatives of 17 beta- and 17 alpha-estradiols: Chemical synthesis and C-13 NMR data [J].
Dionne, P ;
Ngatcha, BT ;
Poirier, D .
STEROIDS, 1997, 62 (10) :674-681
[8]   C-13 NUCLEAR-MAGNETIC-RESONANCE STUDY OF 17-ALPHA-SUBSTITUTED ESTRADIOLS [J].
DIONNE, P ;
POIRIER, D .
STEROIDS, 1995, 60 (12) :830-836
[9]  
GALLO MA, 1997, SEMIN ONCOL S1, V24
[10]   (S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-2H-1-benzopyran-3-yl]phenyl 2,2-dimethylpropanoate (EM-800): A highly potent, specific, and orally active nonsteroidal antiestrogen [J].
Gauthier, S ;
Caron, B ;
Cloutier, J ;
Dory, YL ;
Favre, A ;
Larouche, D ;
Mailhot, J ;
Ouellet, C ;
Schwerdtfeger, A ;
Leblanc, G ;
Martel, C ;
Simard, J ;
Merand, Y ;
Belanger, A ;
Labrie, C ;
Labrie, F .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (14) :2117-2122